共 50 条
- [2] Investigation of the Factors Affecting Risk-Based Quality Management of Investigator-Initiated Investigational New-Drug Trials for Unapproved Anticancer Drugs in Japan Therapeutic Innovation & Regulatory Science, 2017, 51 : 589 - 596
- [8] Safety-Related Regulatory Actions and Risk Factors for Anticancer Drugs in Japan Pharmaceutical Medicine, 2019, 33 : 45 - 52
- [9] Analysis and enhancement of risk management for ethnic differences in antineoplastic drugs in Japan BMC Health Services Research, 22